Double Digit NASDAQ Stock Winners: BBIG, GAMB, NURO
8:08 am Monday, August 30th, 2021
Following are major stock gainers on Nasdaq in Friday’s trading session:
Vinco Ventures, Inc. (NASDAQ:BBIG) was the active stock gainer on Friday and soared 81% to $5.30. Vinco Ventures, Inc. operates as a consumer product research and development, manufacturing, sales, and fulfillment company in North America, the Asia Pacific, and Europe. It offers toys, plush, homewares, and electronics to retailers, distributors, and manufacturers through e-commerce channels; and personal protective equipment to governmental agencies, hospitals, and distributors. The company was formerly known as Edison Nation, Inc. and changed its name to Vinco Ventures, Inc. in November 2020. Vinco Ventures, Inc. was incorporated in 2017 and is based in Bethlehem, Pennsylvania.
Gambling.com Group Limited (NASDAQ:GAMB) was another notable winner as the stock went up 67% to end the session at $14.19 after the company announced it launched BetArizona.com to help sports bettors sign up for new legal wagering options. Sports betting fans can begin pre-registering for online sportsbooks through BetArizona.com starting on Saturday, August 28th, according to the press release.
“With more than 7 million people, two dozen land-based casinos, five major professional sports teams, two Power 5 conference universities, and Super Bowl LVII in 2023, it’s only a matter of time until Arizona becomes one of the largest regulated online gambling markets in America,” said Max Bichsel, vice president of U.S. Business for Gambling.com Group.
NeuroMetrix, Inc. (NASDAQ:NURO) surged 65% to $16.51. NeuroMetrix is trending across social media platforms. It was among the top three trending stocks on Stocktwits at publication time. NeuroMetrix is a commercial stage healthcare company that produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders and diabetes.
NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes.
